Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 17/20 | 0.70 |
| ▸ | PDE3A | Q14432 | 16/20 | 0.70 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.50 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
| ▸ | SYK | P43405 | 1/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28628042 | 0.90 | PDE3B (0.57) | PDE3BPDE3ANOTUMPDE4APDE4B | |
| SCHEMBL30966654 | 0.88 | PDE3B (0.72) | PDE3BPDE3ANOTUM | |
| SCHEMBL22288449 | 0.88 | PDE3B (0.72) | PDE3BPDE3ANOTUM | |
| SCHEMBL28615454 | 0.87 | PDE3B (0.59) | PDE3BPDE3ANOTUMPDE4APDE4B | |
| SCHEMBL30966651 | 0.84 | PDE3B (0.60) | PDE3BPDE3ANOTUMPDE4APDE4B | |
| SCHEMBL28616726 | 0.83 | PDE3B (0.64) | PDE3BPDE3ANOTUMPDE4APDE4B | |
| SCHEMBL22317778 | 0.83 | PDE3B (0.68) | PDE3BPDE3AASIC3FLT3SYK | |
| SCHEMBL22317556 | 0.83 | PDE3B (0.68) | PDE3BPDE3AASIC3FLT3SYK | |
| SCHEMBL20705328 | 0.83 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL22288556 | 0.83 | PDE3B (0.68) | PDE3BPDE3AASIC3FLT3SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113348165-B | 1,2, 4-Triazin-3 (2H) -one compounds for the treatment of hyperproliferative diseases | 拜耳股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-113348165-A | 1,2, 4-triazin-3 (2H) -one compounds for the treatment of hyperproliferative diseases | 拜耳股份有限公司 | 2021-09-03 | — | — | CN | disclosed |